Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC is a multinational pharmaceutical company that develops, manufactures, and markets a wide range of branded and non-branded generic and in-licensed products. Its primary function is to deliver high-quality and affordable medicines to patients around the globe, with a particular focus on specialized therapeutic areas such as oncology, infectious diseases, and cardiovascular health. Hikma operates through three main business segments: Injectables, Generics, and Branded. Each segment plays a crucial role in meeting specific market demands, such as the supply of injectable medicines for hospitals and clinics, cost-effective generic drugs for consumers, and branded pharmaceuticals tailored for specific regional needs. The company has significant market presence in the United States, Europe, and the Middle East and North Africa (MENA) regions. With a strong emphasis on research and development, Hikma Pharmaceuticals PLC continues to contribute significantly to global healthcare by enhancing access to essential medicines and fostering innovation in pharmaceutical practices. Founded in 1978, it has grown into a vital player in the pharmaceutical sector.